Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses

Andrew L. Mellor, Derin B. Keskin, Theodore Johnson, Phillip Chandler, David H. Munn

Research output: Contribution to journalArticle

246 Citations (Scopus)

Abstract

Pharmacological inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine gestation results in fetal allograft rejection and blocks the ability of murine CD8+ dendritic cells to suppress delayed-type hypersensitivity responses to tumorassociated peptide Ags. These observations suggest that cells expressing IDO inhibit T cell responses in vivo. To directly evaluate the hypothesis that cells expressing IDO inhibit T cell responses, we prepared IDO-transfected cell lines and transgenic mice overexpressing IDO and assessed allogeneic T cell responses in vitro and in vivo. T cells cocultured with IDO-transfected cells did not proliferate but expressed activation markers. The potency of allogeneic T cell responses was reduced significantly when mice were preimmunized with IDO-transfected cells. In addition, adoptive transfer of alloreactive donor T cells yielded reduced numbers of donor T cells when injected into IDO-transgenic recipient mice. These outcomes suggest that genetically enhanced IDO activity inhibited T cell proliferation in vitro and in vivo. Genetic manipulation of IDO activity may be of therapeutic utility in suppressing undesirable T cell responses.

Original languageEnglish (US)
Pages (from-to)3771-3776
Number of pages6
JournalJournal of Immunology
Volume168
Issue number8
DOIs
StatePublished - Apr 15 2002

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
T-Lymphocytes
Transgenic Mice
Adoptive Transfer
Delayed Hypersensitivity
Dendritic Cells
Allografts
Cell Proliferation
Pharmacology

ASJC Scopus subject areas

  • Immunology

Cite this

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. / Mellor, Andrew L.; Keskin, Derin B.; Johnson, Theodore; Chandler, Phillip; Munn, David H.

In: Journal of Immunology, Vol. 168, No. 8, 15.04.2002, p. 3771-3776.

Research output: Contribution to journalArticle

Mellor, Andrew L. ; Keskin, Derin B. ; Johnson, Theodore ; Chandler, Phillip ; Munn, David H. / Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. In: Journal of Immunology. 2002 ; Vol. 168, No. 8. pp. 3771-3776.
@article{391f5ad50c8f4794a603367e2d5eca74,
title = "Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses",
abstract = "Pharmacological inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine gestation results in fetal allograft rejection and blocks the ability of murine CD8+ dendritic cells to suppress delayed-type hypersensitivity responses to tumorassociated peptide Ags. These observations suggest that cells expressing IDO inhibit T cell responses in vivo. To directly evaluate the hypothesis that cells expressing IDO inhibit T cell responses, we prepared IDO-transfected cell lines and transgenic mice overexpressing IDO and assessed allogeneic T cell responses in vitro and in vivo. T cells cocultured with IDO-transfected cells did not proliferate but expressed activation markers. The potency of allogeneic T cell responses was reduced significantly when mice were preimmunized with IDO-transfected cells. In addition, adoptive transfer of alloreactive donor T cells yielded reduced numbers of donor T cells when injected into IDO-transgenic recipient mice. These outcomes suggest that genetically enhanced IDO activity inhibited T cell proliferation in vitro and in vivo. Genetic manipulation of IDO activity may be of therapeutic utility in suppressing undesirable T cell responses.",
author = "Mellor, {Andrew L.} and Keskin, {Derin B.} and Theodore Johnson and Phillip Chandler and Munn, {David H.}",
year = "2002",
month = "4",
day = "15",
doi = "10.4049/jimmunol.168.8.3771",
language = "English (US)",
volume = "168",
pages = "3771--3776",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "8",

}

TY - JOUR

T1 - Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses

AU - Mellor, Andrew L.

AU - Keskin, Derin B.

AU - Johnson, Theodore

AU - Chandler, Phillip

AU - Munn, David H.

PY - 2002/4/15

Y1 - 2002/4/15

N2 - Pharmacological inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine gestation results in fetal allograft rejection and blocks the ability of murine CD8+ dendritic cells to suppress delayed-type hypersensitivity responses to tumorassociated peptide Ags. These observations suggest that cells expressing IDO inhibit T cell responses in vivo. To directly evaluate the hypothesis that cells expressing IDO inhibit T cell responses, we prepared IDO-transfected cell lines and transgenic mice overexpressing IDO and assessed allogeneic T cell responses in vitro and in vivo. T cells cocultured with IDO-transfected cells did not proliferate but expressed activation markers. The potency of allogeneic T cell responses was reduced significantly when mice were preimmunized with IDO-transfected cells. In addition, adoptive transfer of alloreactive donor T cells yielded reduced numbers of donor T cells when injected into IDO-transgenic recipient mice. These outcomes suggest that genetically enhanced IDO activity inhibited T cell proliferation in vitro and in vivo. Genetic manipulation of IDO activity may be of therapeutic utility in suppressing undesirable T cell responses.

AB - Pharmacological inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine gestation results in fetal allograft rejection and blocks the ability of murine CD8+ dendritic cells to suppress delayed-type hypersensitivity responses to tumorassociated peptide Ags. These observations suggest that cells expressing IDO inhibit T cell responses in vivo. To directly evaluate the hypothesis that cells expressing IDO inhibit T cell responses, we prepared IDO-transfected cell lines and transgenic mice overexpressing IDO and assessed allogeneic T cell responses in vitro and in vivo. T cells cocultured with IDO-transfected cells did not proliferate but expressed activation markers. The potency of allogeneic T cell responses was reduced significantly when mice were preimmunized with IDO-transfected cells. In addition, adoptive transfer of alloreactive donor T cells yielded reduced numbers of donor T cells when injected into IDO-transgenic recipient mice. These outcomes suggest that genetically enhanced IDO activity inhibited T cell proliferation in vitro and in vivo. Genetic manipulation of IDO activity may be of therapeutic utility in suppressing undesirable T cell responses.

UR - http://www.scopus.com/inward/record.url?scp=0037090313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037090313&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.168.8.3771

DO - 10.4049/jimmunol.168.8.3771

M3 - Article

VL - 168

SP - 3771

EP - 3776

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 8

ER -